Eurofins MWG Operon, a Eurofins Genomics Company, Adds Lawrence Smith as New Chief Operations Officer

Share Article

Smith Brings Diverse Business Experience to the Genomics Market

Lawrence (Larry) Smith has joined Eurofins MWG Operon, Inc., a Eurofins Genomics company, as their new Chief Operations Officer. New COO Smith is excited about the challenges of this position. “I am thrilled to join the Eurofins Genomics team and build upon our excellent performance and reputation for providing our customers with a full range of high-quality genomic products and services.” As Eurofins Genomics continues to expand their services and product offerings, Smith’s extensive operations and organizational leadership experience will be an asset as the company maintains its strong growth and performance.

Mr. Smith joins Eurofins following his role as CEO and President of Mitsubishi Chemical’s Mytex Polymers US Corporation. There, he successfully guided the organization through the difficult economic period impacted by the global financial crisis and the 2011 Japan earthquake and tsunami. Prior to his experience at Mitsubishi, Mr. Smith held various leadership roles in Terex Corporation and Exxon Mobil Corporation.

CEO Martin Kunz commented on Smith’s recruitment. “We’re confident that Eurofins Genomics will thrive with Larry as COO of Eurofins Genomics. His international experience and his past success in doubling revenue in a highly competitive environment make him the ideal candidate,” stated Kunz. “Larry’s management expertise, specifically in logistics and operations, will complement the strengths and experience of our Eurofins Genomics management team.”

More information about Eurofins Genomics can be found at

About Eurofins MWG Operon, a Eurofins Genomics Company
Eurofins MWG Operon Inc., a Eurofins Genomics company, is an international provider of DNA sequencing services, genotyping services, DNA synthesis products and bioinformatics services for pharma, diagnostics, food, agriculture, biotechnological and research markets. The company's strengths are its customer convenience, fast delivery and high quality services in industrial scale for the life science industries and academic research institutions around the world.

Eurofins Genomics’ services are tailored for pharma, diagnostics, agriculture, food, biotechnology and research applications worldwide offering full genomic services in various market segments. Together with the international network of the Eurofins Group, Eurofins Genomics provides an outstanding team of experts and a broad range of technologies around the core business lines DNA & RNA oligonucleotides, custom DNA and next generation sequencing, gene synthesis and molecular biology, as well as genotyping and gene expression.

Eurofins Genomics operates leading R&D and production sites in the USA (Huntsville, AL and Louisville, KY), Germany (Ebersberg), India (Bangalore) and Japan (Tokyo). For more information, please visit

© Eurofins MWG Operon, Inc. A Eurofins Genomics Company.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Donna Brown
Visit website